Abstract:Shiyang Wang, 1, 2 Tianlong Wang, 1 Li Wang, 1 Liansheng Zhong, 3 Kai Li 2 1 Department of Geriatric Surgery, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China; 2 Department of Surgical Oncology, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China; 3 Department of Bioinformatics, College of Life Science, China Medical University, Shenyang 110001, People's Republic of China Correspondence: Kai Li Department of Surgical Oncology, The First Hospital, China Medical University, Shenyang 110001, People's Republic of China Tel +86-13998245233 Email cmu_likai@163.com Background: RING finger protein 126 (RNF126), as a novel E3 ubiquitin ligase, plays an oncogenic role in several solid cancers. But its potential role in colorectal cancer (CRC) that harbored 50% mutant p53, to our knowledge, is rarely reported. Materials and Methods: We investigated the clinical significance and relationship of RNF126 and p53 in CRC tissues and cells. Meanwhile, WB, qRT-PCR, co-IP, MTT, and transwell were used to investigate the function and molecular mechanism of RNF126 in regulating malignant biology in vitro. Results: RNF126 was overexpressed in human CRC specimens, which was tightly associated with tumor size ( P =0.021), T stage ( P =0.030), lymph node metastasis ( P =0.006), TNM stage ( P =0.001), and the poor survival ( P =0.003) of CRC patients. RNF126 had no association with p53 mutation in CRC specimens, and in p53 mutant Colo-205 and SW620 cells. However, in p53 wildtype HCT116 and HCT-8 cells, RNF126 silencing upregulated p53 and p21 but inhibited Rb phosphorylation at Serine 780 (pRb), which was inhibited by p53siRNA. Conversely, RNF126 overexpression downregulated p53 and p21 but promoted pRb expression, which was reversed by a classic proteasome inhibitor, MG132. However, the mRNA levels of above target genes were unchanged, implying a ubiquitination dependent post-translational modification involving in above regulation. Meanwhile, RNF126 was co-immunoprecipitated with p53 and p21 to form a triple complex. RNF126 silencing and overexpression inhibited and promoted p53 ubiquitination and degradation in vitro, respectively. In addition, p53siRNA reversed RNF126 silencing-inhibited cell proliferation, drug resistance, and cell mobility in HCT116 cells. Conversely, MG132 inhibited RNF126 overexpression-promoted above cell biology in HCT-8 cells. Conclusion: Overexpression of RNF126 was remarkably associated with multiple advanced clinical characters of CRC patients independent of mutant p53. RNF126 promotes cell proliferation, mobility, and drug resistance in CRC via enhancing p53 ubiquitination and degradation. Keywords: RING finger protein 126, p53, ubiquitination, colorectal cancer

Rnf2/Ring1b Negatively Regulates P53 Expression In Selective Cancer Cell Types To Promote Tumor Development

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Abstract 3509: Knockdown of RNF2 Induces Apoptosis by Regulating MDM2 and P53 Stability

Figure S5 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

RNF12 Promotes P53-Dependent Cell Growth Suppression and Apoptosis by Targeting MDM2 for Destruction.

Figure S6 from the E3 Ligase RING1 Targets P53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Figure S2 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Abstract 2988: Loss of Rbm38 Cooperates with Mutant P53 to Promote Lymphomagenesis Through Downregulation of Pten

Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187

Figure S1 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Figure S4 from The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Ring Finger Protein 2 Promotes Colorectal Cancer Progression by Suppressing Early Growth Response 1

RNF2 Promotes the Progression of Colon Cancer by Regulating Ubiquitination and Degradation of IRF4.

RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma

Microrna-1827 Represses MDM2 to Positively Regulate Tumor Suppressor P53 and Suppress Tumorigenesis

Emerging role of RNF2 in cancer: From bench to bedside

E3 Ubiquitin-Ligase RNF138 May Regulate P53 Protein Expression to Regulate the Self-Renewal and Tumorigenicity of Glioma Stem Cells.

Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growth

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

Overexpression of RNF126 Promotes the Development of Colorectal Cancer via Enhancing p53 Ubiquitination and Degradation